Discover

RARE
Ultragenyx Pharmaceutical Inc.
26.95
1 x 26.92
1 x 26.95
bid
ask
+
0.15
0.55%
12:37 PM
timesize
Ytd17.16%
1y-1.62%
26.42
day range
27.59
18.29
52 week range
39.89
Open27.13Prev Close26.80Low26.42High27.59Mkt Cap2.65B
Vol614.51KAvg Vol2.24MEPS-5.84P/E-4.62Forward P/E8.12
Beta0.35Short Ratio4.24Inst. Own110.14%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg27.69200-d Avg26.781yr Est52.84

RARE News

Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up  Following Strong Earnings
defenseworld.net
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up Following Strong Earnings

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE - Get Free Report)'s share price gapped up before the m

Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y
zacks.com
Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

RARE beats Q2 earnings estimates as revenues surge year over year to a record quarterly high, driven

Ultragenyx Pharmaceutical Inc. (RARE) Q2 2026 Earnings Call Transcript
seekingalpha.com
Ultragenyx Pharmaceutical Inc. (RARE) Q2 2026 Earnings Call Transcript

Ultragenyx Pharmaceutical Inc. (RARE) Q2 2026 Earnings Call Transcript

Ultragenyx Pharmaceutical Q2 Earnings Call Highlights
marketbeat.com
Ultragenyx Pharmaceutical Q2 Earnings Call Highlights

Ultragenyx Pharmaceutical NASDAQ: RARE reported second-quarter 2026 revenue of $214 million, led by

Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com
Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Ultragenyx (RARE) give a sense of how the business perfor

Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates
zacks.com
Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates

Ultragenyx (RARE) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estima

Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
globenewswire.com
Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update

Second quarter total revenue of $214 million,  Crysvita® revenue of $156 million and Dojolvi® revenu

Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
globenewswire.com
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update

NOVATO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a b

Earnings Preview: Ultragenyx (RARE) Q2 Earnings Expected to Decline
zacks.com
Earnings Preview: Ultragenyx (RARE) Q2 Earnings Expected to Decline

Ultragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earn

Entropy Technologies LP Grows Position in Ultragenyx Pharmaceutical Inc. $RARE
defenseworld.net
Entropy Technologies LP Grows Position in Ultragenyx Pharmaceutical Inc. $RARE

Entropy Technologies LP grew its position in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) by 80.9%

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a b

Brazilian Rare Earths June 2026 Quarterly Report
globenewswire.com
Brazilian Rare Earths June 2026 Quarterly Report

SYDNEY, July 23, 2026 (GLOBE NEWSWIRE) -- Brazilian Rare Earths Limited (ASX: BRE / OTCQX: BRELY) ('

Fifth Third Bancorp Acquires New Holdings in Ultragenyx Pharmaceutical Inc. $RARE
defenseworld.net
Fifth Third Bancorp Acquires New Holdings in Ultragenyx Pharmaceutical Inc. $RARE

Fifth Third Bancorp bought a new stake in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) during the f

LEADING EDGE MATERIALS ADVANCES MIDSTREAM PROCESSING STRATEGY FOR THE NORRA KÄRR HEAVY RARE EARTH ELEMENTS PROJECT
globenewswire.com
LEADING EDGE MATERIALS ADVANCES MIDSTREAM PROCESSING STRATEGY FOR THE NORRA KÄRR HEAVY RARE EARTH EL

LEADING EDGE MATERIALS ADVANCES MIDSTREAM PROCESSING STRATEGY FOR THE NORRA KÄRR HEAVY RARE EARTH EL

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Ultragenyx Pharmaceutical Inc. (RARE)
globenewswire.com
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Ultragenyx Pharmaceu

SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims

Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
globenewswire.com
Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation,

NOVATO, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) rele

Ultragenyx (RARE) Soars 5.2%: Is Further Upside Left in the Stock?
zacks.com
Ultragenyx (RARE) Soars 5.2%: Is Further Upside Left in the Stock?

Ultragenyx (RARE) saw its shares surge in the last session with trading volume being higher than ave

Ultragenyx: The Setrusumab Reset Creates A Cleaner Rare Disease Opportunity
seekingalpha.com
Ultragenyx: The Setrusumab Reset Creates A Cleaner Rare Disease Opportunity

Ultragenyx (RARE) is transitioning from a broad pipeline to a focused rare disease platform, enterin

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif. , June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a

Small Caps Near Record Highs, Robinhood Rallies 12%: Stock Market Today
benzinga.com
Small Caps Near Record Highs, Robinhood Rallies 12%: Stock Market Today

U.S. stocks traded higher by midday Wednesday, with semiconductor equipment names and small caps lea

Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% a

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

Earnings Scheduled For February 12, 2026
benzinga.com
Earnings Scheduled For February 12, 2026

Benzinga Bulls And Bears: Nike, SpaceX, Ultragenyx — And Chinese Tech Stocks Slide
benzinga.com
Benzinga Bulls And Bears: Nike, SpaceX, Ultragenyx — And Chinese Tech Stocks Slide

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
benzinga.com
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tues

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session
benzinga.com
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving I

Dow Falls Over 100 Points; US Pending Home Sales Rise In November
benzinga.com
Dow Falls Over 100 Points; US Pending Home Sales Rise In November

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For August 5, 2025

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
Earnings Scheduled For February 13, 2025

benzinga.com
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after

benzinga.com
Earnings Scheduled For February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning

benzinga.com
Earnings Scheduled For November 2, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

benzinga.com
Earnings Scheduled For February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fisc

benzinga.com
Earnings Scheduled For November 2, 2022

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 413 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 838 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 528 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 404 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  Monday saw 825 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.